封面
市场调查报告书
商品编码
1391907

家禽抗生素市场:依产品类型、依给药方法、按配销通路、按地区

Poultry Antibiotic Market, By Product Type, By Mode of Administration, By Distribution Channel, By Geography

出版日期: | 出版商: Coherent Market Insights | 英文 155 Pages | 商品交期: 2-3个工作天内

价格
简介目录

预计2023年,全球家禽抗生素市场规模将达20亿美元。预计未来几年将出现温和成长,2023 年至 2030 年复合年增长率为 6%。因此,预计到 2030年终市场规模将达到 30 亿美元。

报告范围 报告详情
基准年 2022年 2023年市场规模 20亿美元
实绩资料 2018-2021 预测期 2023-2030
预测期复合年增长率 6.00% 2030年市场规模预测 30亿美元
图 1. 2023 年按地区分類的全球市场占有率(%)
家禽抗生素市场-IMG1

家禽抗生素主要用于治疗商业性或家庭饲养的鸟类(鸡、火鸡、鹅和鸭)的感染疾病和预防性治疗,以获取其肉、蛋和羽毛。抗生素可以减少进入食品的细菌数量,从而帮助保持鸡的健康并提高食品的安全性。家禽抗生素通常对整个鸡群给药,用于治疗疾病、预防疾病和促进生长。

市场动态:

鸡肉数量的增加、鸡蛋和肉类消费的增加、对家禽保健的日益关注、公众意识的提高以及对安全有效的家禽抗生素的需求不断增加正在推动全球家禽市场的发展,这些都是预计推动抗生素增长的关键因素市场。

例如,2023 年 2 月,法定机构 AgriFutures Australia 宣布了一项针对澳洲价值 41 亿美元的家禽业的五年研究、开发和普及计划。

此外,家禽公司Avec推出永续性宪章,概述家禽业可以改善环境永续性的领域,包括包装、动物福利和抗生素使用。

本研究的主要特点

  • 本报告详细分析了全球家禽抗生素市场,并提供了以2022年为基准年的预测期(2023-2030)的市场规模和年复合成长率(CAGR%)。
  • 它还阐明了各个细分市场的潜在商机,并解释了该市场有吸引力的投资提案矩阵。
  • 它还提供了有关市场驱动因素、抑制因素、机会、新产品发布和核准、市场趋势、区域前景、主要企业采取的竞争策略等的重要考察。
  • 它根据以下参数(例如公司亮点、产品系列、主要亮点、财务实绩和策略)介绍了全球家禽抗生素市场的主要企业。
  • 该报告的见解将帮助行销人员和经营团队就未来的产品发布、类型升级、市场扩张和行销策略负责人资讯的决策。
  • 全球家禽抗生素市场报告迎合了该行业的各种相关人员,如投资者、供应商、产品製造商、经销商、新进业者和财务分析师。
  • 相关人员可以透过用于分析全球家禽抗生素市场的各种策略矩阵来促进他们的决策。

目录:

第一章 研究目的与前提

  • 研究目标
  • 假设
  • 简称

第二章 市场展望

  • 报告说明
    • 市场定义和范围
  • 执行摘要
  • Coherent Opportunity Map(COM)

第三章市场动态、法规及趋势分析

  • 市场动态
    • 促进因素
    • 抑制因素
    • 机会
  • 影响分析
  • 主要亮点
  • 监管场景
  • 产品发布/核准
  • PEST分析
  • 波特的分析
  • 併购场景

第四章家禽抗生素市场-冠状病毒(COVID-19)大流行的影响

  • 新型冠状病毒感染疾病(COVID-19)的流行病学
  • 供需面分析
  • 经济影响

第五章家禽抗生素市场,依产品类型,2018-2030

  • 青霉素
  • 四环素类
  • 大环内酯系列
  • 林可酰胺
  • Aminoglycosides
  • 其他的

第六章 2018-2030年家禽抗生素市场(以给药方式)

  • 口服
  • 注射
  • 其他的

第7章家禽抗生素市场,依配销通路,2018-2030

  • 动物药房
  • 线上管道
  • 其他的

第八章2018-2030年按地区分列的家禽抗生素市场

  • 北美洲
  • 美国
  • 加拿大
  • 欧洲
  • 英国
  • 德国
  • 义大利
  • 法国
  • 西班牙
  • 俄罗斯
  • 其他欧洲国家
  • 亚太地区
  • 中国
  • 日本
  • 印度
  • ASEAN
  • 澳洲
  • 韩国
  • 其他亚太地区
  • 拉丁美洲
  • 巴西
  • 墨西哥
  • 阿根廷
  • 其他拉丁美洲
  • 中东
  • GCC
  • 以色列
  • 其他中东地区
  • 非洲
  • 北非
  • 中部非洲
  • 南非

第9章竞争形势

  • Zoetis Inc.
  • Elanco Animal Health
  • Boehringer Ingelheim Animal Health
  • Merck & Co. Inc.
  • Bayer AG
  • Ceva Sante Animale
  • Virbac
  • Vetoquinol SA
  • Phibro Animal Health Corporation
  • Huvepharma
  • Neogen Corporation
  • Nisseiken Co., Ltd.
  • Venkys India Ltd.
  • Inovio Pharmaceuticals, Inc.

第10章

  • 调查方法
  • 关于出版商
简介目录
Product Code: CMI5709

The global poultry antibiotic market size is estimated to be US$ 2.0 Billion in 2023. The market is expected to experience a moderate growth rate in the coming years, with a projected CAGR of 6% from 2023 to 2030. This would result in an estimated market size of US$ 3.0 Billion by the end of 2030.

Report Coverage Report Details
Base Year: 2022 Market Size in 2023: US$ 2.0 Bn
Historical Data for: 2018 to 2021 Forecast Period: 2023 - 2030
Forecast Period 2023 to 2030 CAGR: 6.00% 2030 Value Projection: US$ 3.0 Bn
Figure 1. Global Poultry Antibiotic Market Share (%), By Region, 2023
Poultry Antibiotic Market - IMG1

Poultry antibiotics are primarily used to treat infectious diseases as well as preventative treatment for birds (chickens, turkeys, geese, and ducks) raised commercially or domestically for meat, eggs, and feathers. Antibiotics help make food safe by keeping chickens healthy and reducing bacteria entering the food supply. Antibiotics in poultry are generally administered to the entire flock and are used for the treatment of disease, disease prevention, and growth promotion.

Market Dynamics:

An increase in the population of chickens, a rise in consumption of eggs and meat, a rise in focus on poultry healthcare, an increase in awareness among people, and an increase in demand for safe and effective poultry antibiotics are major factors expected to drive growth of the global poultry antibiotic market.

For instance, in February 2023, AgriFutures Australia, a statutory authority announced a 5-year research, development, and extension plan for Australia's US$ 4.1 billion chicken meat industry.

Moreover, in December 2022, Avec, poultry trading company, announced the launch of its Sustainability Charter, which outlines areas where the poultry industry can improve its environmental sustainability, like packaging, animal welfare, and the use of antibiotics.

Key features of the study:

  • This report provides in-depth analysis of the global poultry antibiotic market, and provides market size (US$ Billion) and compound annual growth rate (CAGR %) for the forecast period (2023-2030), considering 2022 as the base year.
  • It elucidates potential revenue opportunities across different segments and explains attractive investment proposition matrices for this market.
  • This study also provides key insights about market drivers, restraints, opportunities, new product launches or approval, market trends, regional outlook, and competitive strategies adopted by key players.
  • It profiles key players in the global poultry antibiotic market based on the following parameters such as company highlights, products portfolio, key highlights, financial performance, and strategies.
  • Key companies covered as a part of this study include Zoetis Inc., Elanco Animal Health, Boehringer Ingelheim Animal Health, Merck & Co. Inc., Bayer AG, Ceva Sante Animale, Virbac, Vetoquinol S.A., Phibro Animal Health Corporation, Huvepharma, Neogen Corporation, Nisseiken Co., Ltd., Venkys India Ltd., Inovio Pharmaceuticals, Inc, among others
  • Insights from this report would allow marketers and the management authorities of the companies to make informed decisions regarding their future product launches, type up-gradation, market expansion, and marketing tactics.
  • The global poultry antibiotic market report caters to various stakeholders in this industry including investors, suppliers, product manufacturers, distributors, new entrants, and financial analysts.
  • Stakeholders would have ease in decision-making through various strategy matrices used in analyzing the global poultry antibiotic market

Detailed Segmentation:

  • By Product Type:
    • Penicillins
    • Tetracyclines
    • Macrolides
    • Lincosamides
    • Aminoglycosides
    • Others (Fluoroquinolones, etc.)
  • By Mode of Administration:
    • Oral
    • Injection
    • Others
  • By Distribution Channel:
    • Veterinary Pharmacies
    • Online Channel
    • Others (feed stores, etc.)
  • By Region:
    • North America
    • Latin America
    • Europe
    • Asia Pacific
    • Middle East
    • Africa
  • Company Profiles:
    • Zoetis Inc.
    • Elanco Animal Health
    • Boehringer Ingelheim Animal Health
    • Merck & Co. Inc.
    • Bayer AG
    • Ceva Sante Animale
    • Virbac
    • Vetoquinol S.A.
    • Phibro Animal Health Corporation
    • Huvepharma
    • Neogen Corporation
    • Nisseiken Co., Ltd.
    • Venkys India Ltd.

Table of Contents:

1. Research Objectives and Assumptions

  • Research Objectives
  • Assumptions
  • Abbreviations

2. Market Purview

  • Report Description
    • Market Definition and Scope
  • Executive Summary
    • Market Poultry Antibiotic, By Product Type
    • Market Poultry Antibiotic, By Mode of Administration
    • Market Poultry Antibiotic, By Distribution Channel
    • Market Poultry Antibiotic, By Region
  • Coherent Opportunity Map (COM)

3. Market Dynamics, Regulations, and Trends Analysis

  • Market Dynamics
    • Drivers
    • Restraints
    • Opportunities
  • Impact Analysis
  • Key Highlights
  • Regulatory Scenario
  • Product launch/Approvals
  • PEST Analysis
  • PORTER's Analysis
  • Merger and Acquisition Scenario

4. Poultry Antibiotic Market - Impact of Coronavirus (COVID-19) Pandemic

  • COVID-19 Epidemiology
  • Supply Side and Demand Side Analysis
  • Economic Impact

5. Poultry Antibiotic Market, By Product Type, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Penicillins
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Tetracyclines
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Macrolides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Lincosamides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Aminoglycosides
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

6. Poultry Antibiotic Market, By Mode of Administration, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Oral
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Injection
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

7. Poultry Antibiotic Market, By Distribution Channel, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • Veterinary Pharmacies
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Online Channel
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)
  • Others
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, 2018-2030,(US$ Bn)

8. Poultry Antibiotic Market, By Region, 2018-2030, (US$ Bn)

  • Introduction
    • Market Share Analysis, 2023 and 2030 (%)
    • Y-o-Y Growth Analysis, 2019 - 2030
    • Segment Trends
  • North America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • U.S.
  • Canada
  • Europe
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • U.K.
  • Germany
  • Italy
  • France
  • Spain
  • Russia
  • Rest of Europe
  • Asia Pacific
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • China
  • Japan
  • India
  • ASEAN
  • Australia
  • South Korea
  • Rest of Asia Pacific
  • Latin America
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • Brazil
  • Mexico
  • Argentina
  • Rest of Latin America
  • Middle East
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country, 2018 -2030, (US$ Bn)
  • GCC
  • Israel
  • Rest of Middle East
  • Africa
    • Introduction
    • Market Size and Forecast, and Y-o-Y Growth, By Product Type, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Mode of Administration, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Distribution Channel, 2018-2030,(US$ Bn)
    • Market Size and Forecast, and Y-o-Y Growth, By Country/Region, 2018 -2030, (US$ Bn)
  • North Africa
  • Central Africa
  • South Africa

9. Competitive Landscape

  • Zoetis Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Elanco Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Boehringer Ingelheim Animal Health
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Merck & Co. Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Bayer AG
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Ceva Sante Animale
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Virbac
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Vetoquinol S.A.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Phibro Animal Health Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Huvepharma
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Neogen Corporation
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Nisseiken Co., Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Venkys India Ltd.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies
  • Inovio Pharmaceuticals, Inc.
    • Company Highlights
    • Product Portfolio
    • Key Developments
    • Financial Performance
    • Strategies

10. Section

  • Research Methodology
  • About us